As of close of business last night, Cardlytics Inc’s stock clocked out at $14.49, down -1.02% from its previous closing price of $14.64. In other words, the price has decreased by -$0.15 from its previous closing price. On the day, 3434874 shares were traded. CDLX stock price reached its highest trading level at $15.79 during the session, while it also had its lowest trading level at $13.80.
Ratios:
To gain a deeper understanding of CDLX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.31 and its Current Ratio is at 1.31. In the meantime, Its Debt-to-Equity ratio is 1.97 whereas as Long-Term Debt/Eq ratio is at 1.96.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Craig Hallum on March 15, 2024, Upgraded its rating to Buy and sets its target price to $18 from $10 previously.
On November 29, 2023, Lake Street started tracking the stock assigning a Buy rating and target price of $13.
Wells Fargo Downgraded its Equal Weight to Underweight on September 08, 2022, whereas the target price for the stock was revised from $14 to $13.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 19 ’24 when SOSIN CLIFFORD bought 350,000 shares for $14.16 per share. The transaction valued at 4,956,035 led to the insider holds 6,373,676 shares of the business.
SOSIN CLIFFORD bought 350,000 shares of CDLX for $4,689,685 on Mar 18 ’24. The 10% Owner now owns 6,023,676 shares after completing the transaction at $13.40 per share. On Mar 15 ’24, another insider, SOSIN CLIFFORD, who serves as the 10% Owner of the company, bought 311,715 shares for $13.71 each. As a result, the insider paid 4,274,174 and bolstered with 5,673,676 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CDLX now has a Market Capitalization of 638.26M and an Enterprise Value of 812.52M. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.07 while its Price-to-Book (P/B) ratio in mrq is 4.27. Its current Enterprise Value per Revenue stands at 2.63 whereas that against EBITDA is -8.21.
Stock Price History:
Over the past 52 weeks, CDLX has reached a high of $20.52, while it has fallen to a 52-week low of $2.59. The 50-Day Moving Average of the stock is 8.71, while the 200-Day Moving Average is calculated to be 10.27.
Shares Statistics:
It appears that CDLX traded 1.62M shares on average per day over the past three months and 6.19M shares per day over the past ten days. A total of 44.11M shares are outstanding, with a floating share count of 40.76M. Insiders hold about 7.59% of the company’s shares, while institutions hold 68.51% stake in the company. Shares short for CDLX as of Mar 15, 2024 were 4.48M with a Short Ratio of 2.76, compared to 4.15M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 10.16% and a Short% of Float of 11.57%.
Earnings Estimates
As of right now, 3 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.12 for the current quarter, with a high estimate of -$0.01 and a low estimate of -$0.23, while EPS last year was -$0.25. The consensus estimate for the next quarter is -$0.03, with high estimates of $0.1 and low estimates of -$0.16.
Analysts are recommending an EPS of between $0.56 and -$0.36 for the fiscal current year, implying an average EPS of $0.1. EPS for the following year is $0.5, with 3 analysts recommending between $1.03 and -$0.06.
Revenue Estimates
In the current quarter, 3 analysts expect revenue to total $71.69M. It ranges from a high estimate of $72.4M to a low estimate of $70.99M. As of the current estimate, Cardlytics Inc’s year-ago sales were $64.33M, an estimated increase of 11.40% from the year-ago figure.
A total of 3 analysts have provided revenue estimates for CDLX’s current fiscal year. The highest revenue estimate was $340.7M, while the lowest revenue estimate was $335M, resulting in an average revenue estimate of $337.79M. In the same quarter a year ago, actual revenue was $309.2M, up 9.20% from the average estimate. Based on 3 analysts’ estimates, the company’s revenue will be $381.67M in the next fiscal year. The high estimate is $385.25M and the low estimate is $375.97M. The average revenue growth estimate for next year is up 13.00% from the average revenue estimate for this year.
